Keros Therapeutics Inc reports results for the quarter ended in January - Earnings Summary

Keros Therapeutics

07/08/2024 22:42

* Keros Therapeutics Inc  KROS.OQ  reported a quarterly
adjusted
loss of $1.25​​ per share for the quarter ended in January,
higher than the same quarter last year, when the company
reported EPS of $-1.27.  The mean expectation of twelve analysts
for the quarter was for a loss of $1.23 per share. Wall Street
expected results to range from $-1.43 to $-1.10 per share.
    * Revenue was $37.00 thousand​; analysts expected zero. 
    * Keros Therapeutics Inc's reported EPS for the quarter was
a loss
of $1.25​.
    * The company reported a quarterly loss of $45.26 million.
    * Keros Therapeutics Inc shares had risen by 6.7% this
quarter and
gained 22.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 11 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Keros
Therapeutics Inc is $88.00 
This summary was machine generated from LSEG data August 7 at
09:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.23          -1.25          Missed
 Mar. 31 2024      -1.35          -1.21          Beat
 Dec. 31 2023      -1.37          -1.34          Beat
 Sep. 30 2023      -1.35          -1.33          Beat